BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 10433574)

  • 1. Successful treatment of pulmonary Mycobacterium xenopi infection in a natural killer cell-deficient patient with clarithromycin, rifabutin, and sparfloxacin.
    Schmitt H; Schnitzler N; Riehl J; Adam G; Sieberth HG; Haase G
    Clin Infect Dis; 1999 Jul; 29(1):120-4. PubMed ID: 10433574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of combined clarithromycin and sparfloxacin therapy in a patient with discitis: due to Mycobacterium xenopi.
    Roche B; Rozenberg S; Cambau E; Desplaces N; Dion E; Dubourg G; Koeger AC; Robin H; Vergeron H; Bourgeois P
    Rev Rhum Engl Ed; 1997 Jan; 64(1):64-5. PubMed ID: 9051864
    [No Abstract]   [Full Text] [Related]  

  • 3. [The combination therapy of clarithromycin and sparfloxacin for pulmonary Mycobacterium gordonae infection].
    Tomiyama Y; Maesaki S; Yong B; Higashiyama Y; Miyazaki Y; Tomono K; Tashiro T; Kohno S
    Kekkaku; 1999 May; 74(5):457-61. PubMed ID: 10386036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacies of clarithromycin regimens against Mycobacterium xenopi in mice.
    Lounis N; Truffot-Pernot C; Bentoucha A; Robert J; Ji B; Grosset J
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3229-30. PubMed ID: 11600387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful management of two heart transplant recipients with mycobacterial pulmonary infections.
    Bossert T; Bittner HB; Richter M; Rahmel A; Barten M; Gummert JF; Mohr FW
    Ann Thorac Surg; 2005 Aug; 80(2):719-21. PubMed ID: 16039241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mycobacterium xenopi lung infection in a patient with multiple lung cysts that responded well to chemotherapy: a case report].
    Gochi M; Kaneko Y; Seki A; Saitou Z; Samejima T; Seki Y; Takeda H; Kinoshita A; Kuwano K
    Kekkaku; 2012 Nov; 87(11):733-6. PubMed ID: 23367833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Extracellular and intracellular activity of sparfloxacin against Mycobacterium avium complex and Mycobacterium xenopi].
    Gevaudan MJ; Bollet C; Mallet MN; de Lamballerie X; Sambuc R; de Micco P
    Pathol Biol (Paris); 1992 May; 40(5):443-9. PubMed ID: 1323093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial. The AIDS Clinical Trials Group 196/Terry Beirn Community Programs for Clinical Research on AIDS 009 Protocol Team.
    Benson CA; Williams PL; Cohn DL; Becker S; Hojczyk P; Nevin T; Korvick JA; Heifets L; Child CC; Lederman MM; Reichman RC; Powderly WG; Notario GF; Wynne BA; Hafner R
    J Infect Dis; 2000 Apr; 181(4):1289-97. PubMed ID: 10762562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of pulmonary infection with mycobacterium xenopi].
    Kawamura M; Kusanagi Y; Satou Y; Itou S; Honma M; Shimoide H
    Nihon Kokyuki Gakkai Zasshi; 1998 Jan; 36(1):86-9. PubMed ID: 9611983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating acute bacterial exacerbations of chronic bronchitis in patients unresponsive to previous therapy: sparfloxacin versus clarithromycin.
    Lipsky BA; Unowsky J; Zhang H; Townsend L; Talbot GH
    Clin Ther; 1999 Jun; 21(6):954-65. PubMed ID: 10440620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group.
    Shafran SD; Singer J; Zarowny DP; Phillips P; Salit I; Walmsley SL; Fong IW; Gill MJ; Rachlis AR; Lalonde RG; Fanning MM; Tsoukas CM
    N Engl J Med; 1996 Aug; 335(6):377-83. PubMed ID: 8676931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, placebo-controlled study of rifabutin added to a regimen of clarithromycin and ethambutol for treatment of disseminated infection with Mycobacterium avium complex.
    Gordin FM; Sullam PM; Shafran SD; Cohn DL; Wynne B; Paxton L; Perry K; Horsburgh CR
    Clin Infect Dis; 1999 May; 28(5):1080-5. PubMed ID: 10452638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of characteristics of patients and treatment outcome for pulmonary non-tuberculous mycobacterial infection and pulmonary tuberculosis.
    Al Jarad N; Demertzis P; Jones DJ; Barnes NC; Rudd RM; Gaya H; Wedzicha JA; Hughes DT; Empey DW
    Thorax; 1996 Feb; 51(2):137-9. PubMed ID: 8711643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyarthralgia-arthritis syndrome induced by low doses of rifabutin.
    Le Gars L; Collon T; Picard O; Kaplan G; Berenbaum F
    J Rheumatol; 1999 May; 26(5):1201-2. PubMed ID: 10332992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New antimycobacterial agents.
    Yew WW; Chau CH
    Monaldi Arch Chest Dis; 1996 Oct; 51(5):394-404. PubMed ID: 9009628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Two cases of pulmonary Mycobacterium xenopi infection].
    Yamazaki Y; Fujiuchi S; Matsumoto H; Takahashi T; Takeda A; Fujita Y; Fujikane T; Shimizu T; Nishigaki Y
    Nihon Kokyuki Gakkai Zasshi; 2003 Aug; 41(8):556-60. PubMed ID: 14503343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy.
    Jenkins PA; Campbell IA; Banks J; Gelder CM; Prescott RJ; Smith AP
    Thorax; 2008 Jul; 63(7):627-34. PubMed ID: 18250184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The management of mycobacterial infections in HIV seropositive individuals. Jefferiss Wing Therapeutics and Protocols Group.
    Fisher M; Tomlinson DR; Coker RJ
    Int J STD AIDS; 1996 Jul; 7(4):244-9; quiz 249-51. PubMed ID: 8876354
    [No Abstract]   [Full Text] [Related]  

  • 19. HIV: opportunistic infections.
    Ioannidis J; Wilkinson D
    Clin Evid; 2003 Jun; (9):795-816. PubMed ID: 15366175
    [No Abstract]   [Full Text] [Related]  

  • 20. A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients: excess mortality associated with high-dose clarithromycin. Terry Beirn Community Programs for Clinical Research on AIDS.
    Cohn DL; Fisher EJ; Peng GT; Hodges JS; Chesnut J; Child CC; Franchino B; Gibert CL; El-Sadr W; Hafner R; Korvick J; Ropka M; Heifets L; Clotfelter J; Munroe D; Horsburgh CR
    Clin Infect Dis; 1999 Jul; 29(1):125-33. PubMed ID: 10433575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.